Anagnostopoulos G, Blériot C, Venteclef N, Ginhoux F. Immunometabolic Rewiring: A Tale of Macronutrients and Macrophages. Results Probl Cell Differ. 2024; 74:89-118. doi: 10.1007/978-3-031-65944-7_3. PMID: 39406902.

Bagattin A, Tammaccaro SL, Chiral M, Makinistoglu MP, Zimmermann N, Lerner J, Garbay S, Kuperwasser N, Pontoglio M. HNF1β bookmarking involves Topoisomerase 1 activation and DNA topology relaxation in mitotic chromatin. Cell Rep. 2024; 8;43(10):114805. Epub ahead of print. doi: 10.1016/j.celrep.2024.114805. PMID: 39388351.

Manfroi B, Cuc BT, Sokal A, Vandenberghe A, Temmam S, Attia M, El Behi M, Camaglia F, Nguyen NT, Pohar J, Salem-Wehbe L, Pottez-Jouatte V, Borzakian S, Elenga N, Galeotti C, Morelle G, de Truchis de Lays C, Semeraro M, Romain AS, Aubart M, Ouldali N, Mahuteau-Betzer F, Beauvineau C, Amouyal E, Berthaud R, Crétolle C, Arnould MD, Faye A, Lorrot M, Benoist G, Briand N, Courbebaisse M, Martin R, Van Endert P, Hulot JS, Blanchard A, Tartour E, Leite-de-Moraes M, Lezmi G, Ménager M, Luka M, Reynaud CA, Weill JC, Languille L, Michel M, Chappert P, Mora T, Walczak AM, Eloit M, Bacher P, Scheffold A, Mahévas M, Sermet-Gaudelus I, Fillatreau S. Preschool-age children maintain a distinct memory CD4+ T cell and memory B cell response after SARS-CoV-2 infection. Sci Transl Med. 2024; Sep 18;16(765):eadl1997. Epub 2024 Sep 18. doi: 10.1126/scitranslmed.adl1997. PMID: 39292802.

Kramarska E, Toumi E, Squeglia F, Laverde D, Napolitano V, Frapy E, Autiero I, Sadones O, Huebner J, Skurnik D, Romero-Saavedra F, Berisio R. A rationally designed antigen elicits protective antibodies against multiple nosocomial Gram-positive pathogens. NPJ Vaccines. 2024; Aug 18;9(1):151. doi: 10.1038/s41541-024-00940-x. PMID: 39155280; PMCID: PMC11330964.

Chen H, Moriceau S, Joseph A, Mailliet F, Li S, Tolle V, Duriez P, Dardennes R, Durand S, Carbonnier V, Stoll G, Sauvat A, Lachkar S, Aprahamian F, Alves Costa Silva C, Pan H, Montégut L, Anagnostopoulos G, Lambertucci F, Motiño O, Nogueira-Recalde U, Bourgin M, Mao M, Pan Y, Cerone A, Boedec E, Gouveia ZL, Marmorino F, Cremolini C, Derosa L, Zitvogel L, Kepp O, López-Otín C, Maiuri MC, Perez F, Gorwood P, Ramoz N, Oury F, Martins I, Kroemer G. Acyl-CoA binding protein for the experimental treatment of anorexia. Sci Transl Med. 2024; Aug 14;16(760):eadl0715. Epub 2024 Aug 14. doi: 10.1126/scitranslmed.adl0715. PMID: 39141698.

Fraissenon A, Bayard C, Morin G, Benichi S, Hoguin C, Protic S, Zerbib L, Ladraa S, Firpion M, Blauwblomme T, Naggara O, Duruisseaux M, Delous M, Boitel C, Bringuier PP, Payen L, Legendre C, Kaltenbach S, Balducci E, Villarese P, Asnafi V, Bisdorff A, Guibaud L, Canaud G. Sotorasib for Vascular Malformations Associated with KRAS G12C Mutation. N Engl J Med. 2024; Jul 17. Epub ahead of print. doi: 10.1056/NEJMoa2309160. PMID: 39018528.

Zerbib L, Ladraa S, Fraissenon A, Bayard C, Firpion M, Venot Q, Protic S, Hoguin C, Thomas A, Fraitag S, Duong JP, Kaltenbach S, Balducci E, Lefevre C, Villarese P, Asnafi V, Broissand C, Goudin N, Nemazanyy I, Autret G, Tavitian B, Legendre C, Arzouk N, Minard-Colin V, Chopinet C, Dussiot M, Adams DM, Mirault T, Guibaud L, Isenring P, Canaud G. Targeted therapy for capillary-venous malformations. Signal Transduct Target Ther. 2024; Jun 17;9(1):146. doi: 10.1038/s41392-024-01862-9. PMID: 38880808; PMCID: PMC11180659.

Xiang Y, Mata-Garrido J, Fu Y, Desterke C, Batsché E, Hamaï A, Sedlik C, Sereme Y, Skurnik D, Jalil A, Onifarasoaniaina R, Frapy E, Beche JC, Alao R, Piaggio E, Arbibe L, Chang Y. CBX3 antagonizes IFNγ/STAT1/PD-L1 axis to modulate colon inflammation and CRC chemosensitivity. EMBO Mol Med. 2024; Jun;16(6):1404-1426. doi: 10.1038/s44321-024-00066-6. PMID: 38684864; PMCID: PMC11178889.

Simonin M, Vasseur L, Lengliné E, Lhermitte L, Cabannes-Hamy A, Balsat M, Schmidt A, Dourthe ME, Touzart A, Graux C, Grardel N, Cayuela JM, Arnoux I, Gandemer V, Rigal-Huguet F, Ducassou S, Lheritier V, Chalandon Y, Ifrah N, Dombret H, Macintyre EA, Petit A, Rousselot P, Lambert J, Baruchel A, Boissel N, Asnafi V. NGS-based stratification refines the risk stratification in T-ALL and identifies a Very High-Risk subgroup of patients. Blood. 2024; Jun 7:blood.2023023754. Epub ahead of print. doi: 10.1182/blood.2023023754. PMID: 38848537.

Yamaguchi J, Isnard P, Robil N, de la Grange P, Hoguin C, Schmitt A, Hummel A, Mégret J, Goudin N, Luka M, Ménager MM, Masson C, Zarhrate M, Bôle-Feysot C, Janiszewska M, Polyak K, Dairou J, Baldassari S, Baulac S, Broissand C, Legendre C, Terzi F, Canaud G. PIK3CA inhibition in models of proliferative glomerulonephritis and lupus nephritis. J Clin Invest. 2024; Jun 6:e176402. Epub ahead of print. doi: 10.1172/JCI176402. PMID: 38842935.